Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Amarnath Sharma

Showing results (1-10 of 44) with videos related to

Pageof 5
Sort By:
Expert Opinion on Drug Metabolism & Toxicology|July 9, 2016
Therapeutic protein-drug interactions: plausible mechanisms and assessment strategiesHonghui Zhou, Amarnath Sharma
The AAPS Journal|March 19, 2020
Applying Beta Distribution in Analyzing Bounded Outcome Score DataChuanpu Hu, Honghui Zhou, Amarnath Sharma
Journal of Pharmacokinetics and Pharmacodynamics|July 22, 2017
Landmark and longitudinal exposure-response analyses in drug developmentChuanpu Hu, Honghui Zhou, Amarnath Sharma
The AAPS Journal|July 24, 2020
Facilitating Longitudinal Exposure-Response Modeling of a Composite Endpoint Using the Joint Modeling of Sparsely and Frequently Collected SubcomponentsChuanpu Hu, Honghui Zhou, Amarnath Sharma
The AAPS Journal|July 23, 2020
Application of Beta-Distribution and Combined Uniform and Binomial Methods in Longitudinal Modeling of Bounded Outcome Score DataChuanpu Hu, Honghui Zhou, Amarnath Sharma
Neurosurgical Focus|March 8, 2007
Selective enhancement of cellular oxidative stress by chloroquine: implications for the treatment of glioblastoma multiformeSteven M Toler, Dennis Noe, Amarnath Sharma
Cancer Chemotherapy and Pharmacology|February 8, 2007
Population pharmacokinetics of a HER2 tyrosine kinase inhibitor CP-724,714 in patients with advanced malignant HER2 positive solid tumorsFeng Guo, Stephen P Letrent, Amarnath Sharma
Journal of Pharmacokinetics and Pharmacodynamics|June 22, 2017
Improvement in latent variable indirect response modeling of multiple categorical clinical endpoints: application to modeling of guselkumab treatment effects in psoriatic patientsChuanpu Hu, Bruce Randazzo, Amarnath Sharma, et al.
The AAPS Journal|October 17, 2018
Risk-Based Comparability Assessment for Monoclonal Antibodies During Drug Development: A Clinical Pharmacology PerspectiveYanli Zhuang, Di Chen, Amarnath Sharma, et al.
The AAPS Journal|March 15, 2018
Why Drugs Fail in Late Stages of Development: Case Study Analyses from the Last Decade and RecommendationsDolly A Parasrampuria, Leslie Z Benet, Amarnath Sharma
Pageof 5

Showing results (1-10 of 44) with videos related to

Sort By:
Pageof 5
Expert Opinion on Drug Metabolism & Toxicology|July 9, 2016
Therapeutic protein-drug interactions: plausible mechanisms and assessment strategiesHonghui Zhou, Amarnath Sharma
The AAPS Journal|March 19, 2020
Applying Beta Distribution in Analyzing Bounded Outcome Score DataChuanpu Hu, Honghui Zhou, Amarnath Sharma
Journal of Pharmacokinetics and Pharmacodynamics|July 22, 2017
Landmark and longitudinal exposure-response analyses in drug developmentChuanpu Hu, Honghui Zhou, Amarnath Sharma
The AAPS Journal|July 24, 2020
Facilitating Longitudinal Exposure-Response Modeling of a Composite Endpoint Using the Joint Modeling of Sparsely and Frequently Collected SubcomponentsChuanpu Hu, Honghui Zhou, Amarnath Sharma
The AAPS Journal|July 23, 2020
Application of Beta-Distribution and Combined Uniform and Binomial Methods in Longitudinal Modeling of Bounded Outcome Score DataChuanpu Hu, Honghui Zhou, Amarnath Sharma
Neurosurgical Focus|March 8, 2007
Selective enhancement of cellular oxidative stress by chloroquine: implications for the treatment of glioblastoma multiformeSteven M Toler, Dennis Noe, Amarnath Sharma
Cancer Chemotherapy and Pharmacology|February 8, 2007
Population pharmacokinetics of a HER2 tyrosine kinase inhibitor CP-724,714 in patients with advanced malignant HER2 positive solid tumorsFeng Guo, Stephen P Letrent, Amarnath Sharma
Journal of Pharmacokinetics and Pharmacodynamics|June 22, 2017
Improvement in latent variable indirect response modeling of multiple categorical clinical endpoints: application to modeling of guselkumab treatment effects in psoriatic patientsChuanpu Hu, Bruce Randazzo, Amarnath Sharma, et al.
The AAPS Journal|October 17, 2018
Risk-Based Comparability Assessment for Monoclonal Antibodies During Drug Development: A Clinical Pharmacology PerspectiveYanli Zhuang, Di Chen, Amarnath Sharma, et al.
The AAPS Journal|March 15, 2018
Why Drugs Fail in Late Stages of Development: Case Study Analyses from the Last Decade and RecommendationsDolly A Parasrampuria, Leslie Z Benet, Amarnath Sharma
Pageof 5